NF2 Antibodies

Santa Cruz Biotechnology features a diverse variety of NF2 monoclonal antibodies for research focused on understanding the neurofibromatosis type 2 (NF2) gene and its associated protein, merlin. NF2 monoclonal antibodies are suitable for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The NF2 gene encodes merlin protein, which plays a crucial role in regulating cell growth and maintaining the structural integrity of cells. Mutations in the NF2 gene can lead to the development of tumors, particularly schwannomas and meningiomas, highlighting the significance of merlin in cancer research. Understanding merlin's function is essential for developing targeted therapies and improving patient outcomes. Research utilizing NF2 monoclonal antibodies has revealed important insights into cellular signaling pathways and tumor suppression mechanisms. Investigating merlin's interactions with other proteins has enhanced knowledge about cell adhesion and proliferation control. Current studies continue to uncover new aspects of NF2-related pathways and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of NF2-related diseases and developing innovative therapeutic approaches.